다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

ANOR

Anormed Ord (MM) (ANOR)

Anormed Ord (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ANOR

1

일자	시간	출처	헤드라인	심볼	기업
2006/11/08	06:57	PR Newswire (US)	Genzyme Completes Tender Offer for Outstanding Shares of AnorMED	NASDAQ:ANOR
2006/11/07	14:01	PR Newswire (US)	Genzyme and AnorMED Announce Completion of Hart-Scott-Rodino Review	NASDAQ:ANOR
2006/11/03	14:05	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
2006/11/03	14:05	PR Newswire (US)	AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events	NASDAQ:ANOR
2006/10/26	23:00	PR Newswire (US)	Koronis Pharmaceuticals Appoints Stephen Becker, M.D., Chief Medical Officer	NASDAQ:ANOR	Anormed Ord (MM)
2006/10/23	23:00	PR Newswire (US)	AnorMED completes enrollment in Phase III trial for MOZOBIL on schedule	NASDAQ:ANOR
2006/10/17	23:47	PR Newswire (US)	AnorMED and Genzyme reach agreement on acquisition	NASDAQ:ANOR
2006/10/12	11:03	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
2006/10/12	10:47	PR Newswire (US)	AnorMED has determined Genzyme's offer is a 'superior proposal'	NASDAQ:ANOR
2006/10/11	13:30	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
2006/10/11	13:30	PR Newswire (US)	AnorMED announces receipt of proposal from Genzyme Corporation	NASDAQ:ANOR
2006/10/10	23:50	PR Newswire (US)	Genzyme Announces Proposal to Increase Its Offer to Acquire AnorMED to $13.50 Per Share in Cash	NASDAQ:ANOR
2006/10/07	01:41	PR Newswire (US)	Genzyme Extends Deadline for Tender Offer to Acquire AnorMED Inc.	NASDAQ:ANOR	Anormed Ord (MM)
2006/10/06	12:10	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
2006/10/06	12:10	PR Newswire (US)	AnorMED Board recommends shareholders accept Millennium offer	NASDAQ:ANOR
2006/10/05	13:36	PR Newswire (US)	AnorMED board continues to recommend that shareholders accept Millennium's planned tender offer	NASDAQ:ANOR
2006/09/26	23:46	PR Newswire (US)	Millennium Agrees to Acquire AnorMED, Adding Phase III Oncology Product with Planned Near Term Launch Date	NASDAQ:ANOR
2006/09/26	23:45	PR Newswire (US)	AnorMED agrees to support a planned tender offer of US$12 per share from Millennium Pharmaceuticals	NASDAQ:ANOR
2006/09/25	14:23	PR Newswire (US)	Approval of FOSRENOL in the United Kingdom triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
2006/09/20	23:00	PR Newswire (US)	AnorMED reports on Annual General Meeting	NASDAQ:ANOR
2006/09/19	21:30	PR Newswire (US)	AnorMED amends license agreement for cancer drug	NASDAQ:ANOR
2006/09/19	21:30	PR Newswire (US)	Poniard Pharmaceuticals Expands Picoplatin Agreement to Include Exclusive Worldwide Rights and Improved Financial Terms and Cond	NASDAQ:ANOR
2006/09/18	23:00	PR Newswire (US)	Approval of FOSRENOL in Germany triggers U.S.$3 million payment to AnorMED	NASDAQ:ANOR
2006/09/16	10:22	PR Newswire (US)	AnorMED Provides Update on Limited Duration Shareholder Rights Plan	NASDAQ:ANOR
2006/09/13	02:57	PR Newswire (US)	Atticus Capital LP Opposes Genzyme bid for AnorMED	NASDAQ:ANOR

검색 관련기사 보기:NASDAQ:ANOR

1

BNP Paribas (QX)

Deutsche Telekom (QX)

American Express

Bank of America

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관